| Record ID | ia:isbn_9791905064907 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/isbn_9791905064907/isbn_9791905064907_marc.xml |
| Download MARC binary | https://www.archive.org/download/isbn_9791905064907/isbn_9791905064907_meta.mrc |
LEADER: 01337cam 22004094a 4500
001 ocm69672708
003 OCoLC
005 20201217140650.0
008 060208s2004 enka b 001 0 eng
040 $aNLM$beng$cNLM$dYDXCP$dOCLCQ$dNLM$dOCLCO$dOCLCA$dDCT
016 7 $a101267202$2DNLM
020 $a9781905064908
020 $a190506490X
035 $a(OCoLC)69672708
042 $apcc
060 00 $a2006 D-290
060 10 $aWD 200.5.H8$bL763 2004
082 04 $a616.399 706 1$222
245 00 $aLipid disorders /$ceditor, George Kassianos [and others].
260 $aLong Hanborough, Oxfordshire :$bCSF Medical Communications,$c©2004.
300 $axviii, 218 pages :$billustrations.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aBestmedicine
500 $aBased on articles from Drugs in Context journal.
504 $aIncludes bibliographical references and index.
650 12 $aDyslipidemias$xdrug therapy.
650 22 $aHypolipidemic Agents$xtherapeutic use.
655 2 $aPopular Work.
700 1 $aKassianos, George C.
730 0 $aDrugs in context.
830 0 $aBestmedicine.
938 $aYBP Library Services$bYANK$n100426296
029 0 $aNLM$b101267202
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 3 OTHER HOLDINGS